3 Mad-Money Funds
These may not be good core holdings, but they are among the best sector funds around.
Susan Dziubinski: Hi, I'm Susan Dziubinski for Morningstar. We talk a lot about building a portfolio of sensible core funds that can help you reach your goals, but sometimes you may want to take a bit of a gamble on a particular sector at the outskirts of your portfolio. Here are three funds that may not be good core holdings, but they are among the best sector funds around.
Thomas Lancereau: Gold-rated Vanguard Health Care is one of the best in its category. Its subadvisor, Wellington Asset Management, has a stable and experienced team dedicated to this sector including lead manager Jean Hynes, who has worked with the team for almost three decades. The portfolio is broadly diversified across the different healthcare industries such as pharma, biotech, and medical-devices companies. Exposure to foreign stocks is higher than the normal with around 25% of assets in non-U.S. stocks. This fund is the biggest one in the Morningstar health category. It has more than $40 billion in assets under management, but it's not a challenge as it mostly invests in large caps. The fund has delivered for investors. It's outperforming index benchmark over multiple time periods as well as peers on a risk-adjusted basis. Volatility is lower than peers as the category includes biotech-only firms. Plus, fees are amongst the lowest in the category, which makes this strategy even more appealing.
Nick Watson does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.